Literature DB >> 7787419

Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping.

M E Greene1, B Blumberg, O W McBride, H F Yi, K Kronquist, K Kwan, L Hsieh, G Greene, S D Nimer.   

Abstract

The nuclear receptor superfamily of transcription factors, which includes the retinoic acid receptors and v-erb A, play important roles in the molecular control of hematopoiesis. To identify nuclear receptors expressed in hematopoietic cells, we screened a human bone marrow cDNA library using a degenerate oligonucleotide and isolated a 1.85-kb full-length cDNA encoding a new human member of this superfamily, the peroxisome proliferator activated receptor gamma (hPPAR gamma). Two different hPPAR gamma transcripts were expressed in hematopoietic cells: a 1.85-kb transcript, which corresponds to the full-length mRNA (PPAR gamma 1), and a 0.65-kb transcript (PPAR gamma 2), which cannot encode all of the nuclear receptor functional domains. Normal neutrophils and peripheral blood lymphocytes, as well as circulating leukemic cells from patients with AML, ALL, and CML, express only PPAR gamma 2 on Northern blot analysis. In contrast, only the PPAR gamma 1 transcript was detected in a variety of human leukemia cell lines and in cultured normal primary bone marrow stromal cells. Both transcripts were detected in various fetal and adult nonhematopoietic tissues. We mapped the location of the hPPAR gamma gene to human chromosome 3p25 by somatic cell hybridization and linkage analysis. PPARs have been shown to be activated by peroxisome proliferating agents, long-chain fatty acids and arachidonic acid. Human PPAR gamma, although homologous to the PPAR gamma s of other species, has unique sequence and amino acid differences. Identification of hPPAR gamma will allow further understanding of its role in human cellular leukotriene, prostaglandin, and peroxide degradative or synthetic pathways, as well as its role in lipid metabolism and regulation of adipocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7787419      PMCID: PMC6134382     

Source DB:  PubMed          Journal:  Gene Expr        ISSN: 1052-2166


  63 in total

1.  Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome.

Authors:  J Dausset; H Cann; D Cohen; M Lathrop; J M Lalouel; R White
Journal:  Genomics       Date:  1990-03       Impact factor: 5.736

2.  A systematic analytical chemistry/cell assay approach to isolate activators of orphan nuclear receptors from biological extracts: characterization of peroxisome proliferator-activated receptor activators in plasma.

Authors:  C D Banner; M Göttlicher; E Widmark; J Sjövall; J J Rafter; J A Gustafsson
Journal:  J Lipid Res       Date:  1993-09       Impact factor: 5.922

3.  v-erbA oncogene function in neoplasia correlates with its ability to repress retinoic acid receptor action.

Authors:  M Sharif; M L Privalsky
Journal:  Cell       Date:  1991-09-06       Impact factor: 41.582

4.  Strategies for multilocus linkage analysis in humans.

Authors:  G M Lathrop; J M Lalouel; C Julier; J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

5.  Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.

Authors:  E Mayatepek; W D Lehmann; J Fauler; D Tsikas; J C Frölich; R B Schutgens; R J Wanders; D Keppler
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

6.  The ontogeny of peroxisome-proliferator-activated receptor gene expression in the mouse and rat.

Authors:  F Beck; S Plummer; P V Senior; S Byrne; S Green; W J Brammar
Journal:  Proc Biol Sci       Date:  1992-02-22       Impact factor: 5.349

7.  Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently.

Authors:  M Leid; P Kastner; R Lyons; H Nakshatri; M Saunders; T Zacharewski; J Y Chen; A Staub; J M Garnier; S Mader
Journal:  Cell       Date:  1992-01-24       Impact factor: 41.582

8.  Evolution of the nuclear receptor gene superfamily.

Authors:  V Laudet; C Hänni; J Coll; F Catzeflis; D Stéhelin
Journal:  EMBO J       Date:  1992-03       Impact factor: 11.598

Review 9.  The steroid and thyroid hormone receptor superfamily.

Authors:  R M Evans
Journal:  Science       Date:  1988-05-13       Impact factor: 47.728

10.  Chromosomal location of human kappa and lambda immunoglobulin light chain constant region genes.

Authors:  O W McBride; P A Hieter; G F Hollis; D Swan; M C Otey; P Leder
Journal:  J Exp Med       Date:  1982-05-01       Impact factor: 14.307

View more
  79 in total

Review 1.  Orphan nuclear receptors as targets for drug development.

Authors:  Subhajit Mukherjee; Sridhar Mani
Journal:  Pharm Res       Date:  2010-04-06       Impact factor: 4.200

2.  Influence of peroxisome proliferator-activated receptor gamma gene polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients.

Authors:  S Sauder; H Kölsch; D Lütjohann; A Schulz; K von Bergmann; W Maier; R Heun
Journal:  J Neural Transm (Vienna)       Date:  2005-01-24       Impact factor: 3.575

3.  Fluorine-18 labeling and biodistribution studies on peroxisome proliferator-activated receptor-gamma ligands: potential positron emission tomography imaging agents.

Authors:  Byung Chul Lee; Carmen S Dence; Haibing Zhou; Ephraim E Parent; Michael J Welch; John A Katzenellenbogen
Journal:  Nucl Med Biol       Date:  2009-02       Impact factor: 2.408

4.  Localization of mouse peroxisome proliferator-activated receptor gamma on chromosome 6.

Authors:  K Reue; Y Xia; V W Shi; R D Cohen; C Welch; A J Lusis
Journal:  Mamm Genome       Date:  1996-05       Impact factor: 2.957

Review 5.  Pleiotropic role of PPARγ in intracerebral hemorrhage: an intricate system involving Nrf2, RXR, and NF-κB.

Authors:  Xiu-Rong Zhao; Nicole Gonzales; Jaroslaw Aronowski
Journal:  CNS Neurosci Ther       Date:  2014-11-28       Impact factor: 5.243

6.  Role of the ACE ID and PPARG P12A Polymorphisms in Genetic Susceptibility of Diabetic Nephropathy in a South Indian Population.

Authors:  Lakkakula Vks Bhaskar; Sultana Mahin; Raju Thankabai Ginila; Periyasamy Soundararajan
Journal:  Nephrourol Mon       Date:  2013-05-26

Review 7.  The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity.

Authors:  Francesco S Celi; Alan R Shuldiner
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

Review 8.  PPARgamma in human and mouse physiology.

Authors:  Sami Heikkinen; Johan Auwerx; Carmen A Argmann
Journal:  Biochim Biophys Acta       Date:  2007-03-27

Review 9.  Peroxisome proliferator-activated receptor (PPAR): balance for survival in parasitic infections.

Authors:  Marion M Chan; Kyle W Evans; Andrea R Moore; Dunne Fong
Journal:  J Biomed Biotechnol       Date:  2010-02-10

10.  Current understanding of the role of PPARγ in gastrointestinal cancers.

Authors:  Bing Zou; Liang Qiao; Benjamin C Y Wong
Journal:  PPAR Res       Date:  2009-10-26       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.